<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We analyzed activating mutations of N-ras and K-ras by the polymerase chain reaction and oligonucleotide hybridization in <z:e sem="disease" ids="C0947743,C0018939" disease_type="Disease or Syndrome" abbrv="">hematological disorders</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Activating mutations of these codons were detected in 4 of 20 cases of <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) and 15 of 77 cases of <z:hpo ids='HP_0004808'>acute myelogenous leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) </plain></SENT>
<SENT sid="2" pm="."><plain>Our of 19 cases of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> who carried active mutations, 7 cases were found to have two or more distinct mutations in activating codons of N-ras and K-ras </plain></SENT>
<SENT sid="3" pm="."><plain>Ras mutation was found preferentially in progressive disease such as <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> with excess of blasts (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>) of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e> in transformation (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>-t) </plain></SENT>
<SENT sid="4" pm="."><plain>A relatively high incidence of ras mutation was found in M5 <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> (40%) </plain></SENT>
<SENT sid="5" pm="."><plain>No ras mutations were found in other <z:e sem="disease" ids="C0947743,C0018939" disease_type="Disease or Syndrome" abbrv="">hematological disorders</z:e>, such as <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo> and <z:hpo ids='HP_0005506'>chronic myelogenous-leukemia</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>The most frequent amino acid substitution was that of an <z:chebi fb="0" ids="29995">aspartate</z:chebi> for glycine at codon 12 of N-ras resulting from G to A mutation (11/35) </plain></SENT>
<SENT sid="7" pm="."><plain>The survival of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> patients who carried ras mutations showed no significant differences from those without ras mutations calculated by Kaplan-Meier </plain></SENT>
<SENT sid="8" pm="."><plain>Seven cases of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and 7 cases of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> patients could be investigated at various points during their clinical course </plain></SENT>
<SENT sid="9" pm="."><plain>Among these 14 cases, we found 2 interesting cases of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>The first case lost multiple clones carrying ras mutations during disease progression, the second case acquired mutation of the ras gene during disease progression </plain></SENT>
<SENT sid="11" pm="."><plain>These results suggested that multiple point mutations of ras genes may not be initiating events but may contribute to a <z:e sem="disease" ids="C1516669" disease_type="Neoplastic Process" abbrv="">clonal evolution</z:e> of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> </plain></SENT>
</text></document>